Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Novartis Pharmaceuticals
Daniel S W Tan; Enriqueta Felip; Gilberto de Castro; Benjamin J Solomon; Alastair Greystoke; Byoung Chul Cho; Manuel Cobo; Tae Min Kim; Sandip Ganguly; Enric Carcereny; Luis Paz-Ares; Jaafar Bennouna; Marina Chiara Garassino; Michael Schenker; Sang-We Kim; Jan C Brase; Denise Bury-Maynard; Vanessa Q Passos; Stéphanie Deudon; Bharani Dharan; Yuanbo Song; Rafael Caparica; Bruce E Johnson